Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Annals of Translational Medicine|July 19, 2021
Considerations for immunotherapy in patients with cancer and comorbid immune dysfunctionVaia Florou, Sonam Puri, Ignacio Garrido-Laguna, et al.
BMJ Case Reports|January 22, 2025
Gemcitabine-induced myositis in a patient with pancreatic cancerZach Rubnitz, Chris Nevala-Plagemann, Vaia Florou, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycleSnehal Gajiwala, Anna Torgeson, Ignacio Garrido-Laguna, et al.
ESMO Open|August 20, 2019
Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumabChristopher Nevala-Plagemann, Justin Moser, Glynn Weldon Gilcrease, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Large database utilization in health outcomes research in pancreatic cancer: an updateAnna Torgeson, Randa Tao, Ignacio Garrido-Laguna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2011
Novel therapeutic targets in non-small cell lung cancerFilip Janku, Ignacio Garrido-Laguna, Lubos B Petruzelka, et al.
Journal of Gastrointestinal Oncology|January 10, 2024
Durable response to first-line PARP inhibition in BRCA-mutated metastatic cholangiocarcinoma: case reportJarrod T Smith, Shashank Sama, Vaia Florou, et al.
BMC Cancer|October 12, 2022
Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world studyLaura Miotke, Christopher Nevala-Plagemann, Jian Ying, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United StatesAndrew Trunk, Matthew Braithwaite, Christopher Nevala-Plagemann, et al.
Immunotherapy|September 8, 2017
Case report: pembrolizumab-induced Type 1 diabetes in a patient with metastatic cholangiocarcinomaMatthew A Smith-Cohn, David Gill, Benjamin N Voorhies, et al.
Pageof 11